Matrix OI® FlexIt
Matrix OI® products are verified for osteoinductivity prior to release for distribution. In-vivo Matrix OI® test results demonstrate all five (5) bone-forming elements present (Chondrocytes, Osteocytes, Bone Marrow, Cartilage, and New Bone). In-vitro Matrix OI® test results for BMP levels demonstrate CellRight’s Matrix OI® products have up to 19x the native BMP levels of the BMP-2 control.
The grafts are freeze-dried and sterilized using low-dose gamma irradiation to achieve a sterility assurance level (SAL) of 10-6. The grafts should be stored in ambient temperatures (59-86º F or 15-30º C) and have a shelf-life of up to five (5) years from the date of packaging.
CellRight’s proprietary next-generation BioRinse™ processing technology has been proven to preserve native bone morphogenic proteins (BMP’s). Matrix OI® FlexIT is indicated for use in craniomaxillofacial applications including cranial repair, orbital floor, and zygomatic fractures, involving sutures, plates, anchors, and other fixation devices. Other uses for Matrix OI® FlexIT include acetabular reconstruction, posterolateral spinal procedures, long-bone fracture plate, non-unions, and dental procedures.